Sarepta Therapeutics
The Lead Study Statistician will provide end-to-end statistical leadership for clinical trials, overseeing study design, protocol development, analysis, and regulatory submissions. As the portfolio advances, the role may expand to Program Statistical Lead, offering strategic guidance across development stages and partnering with senior leadership on key program decisions. This position requires extensive hands-on experience in clinical trial design and statistical programming within the pharmaceutical or biotechnology industry.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
46% above the average for this role
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago